Quantum量子訊息有限公司
← 最新全球產業報告

Latin America Continuous Glucose Monitoring Device Market

研究執行與發布:Coherent Market Insights · 發布日期 2026-02-23 · 151 頁
由量子訊息有限公司(Quantum Information)在台灣代理銷售與提供授權諮詢。

2026 年市場規模
USD 394.9 Mn
2033 年預估規模
USD 1,100.9 Mn
年複合成長率 CAGR
15.8%

以上數字由 Coherent Market Insights 於本報告中提出,量子訊息原樣引用。

出版商 Coherent Market Insights產業別 Medical Devices出版日期 2026-02-23頁數 151報告編號 CMI2993

授權報價

Single User Price$4,500 USD
Enterprise License$10,000 USD
洽詢購買 申請 Sample
完整報告名稱與涵蓋範圍
Latin America Continuous Glucose Monitoring Device Market, By Component Type (Transmitters, Receivers, Insulin Pumps, Sensors), By End User (Hospitals & Clinics, Homecare, Others (Ambulatory Surgical Centers & Academic Institutes)), By Geography (Mexico, Argentina, Uruguay, Brazil, Colombia, Chile, Peru, Rest of Latin America)

報告摘要

Continuous glucose monitoring devices are considered as significant systems for improving diabetes management by providing better and pain-free blood glucose measurement. Continuous glucose monitoring devices marked a remarkable change in diabetes care, as these devices provide real-time information on blood glucose levels, non-invasively than conventional glucose monitoring devices. Continuous glucose monitoring devices constantly tracks the blood glucose level throughout the day. This device consists of various components such as sensors, transmitters, and receivers for measuring and analyzing the glucose levels. Market Dynamics Latin America continuous glucose monitoring device market is expected to witness significant growth over the forecast period, owing to increasing incidence of diabetes in Latin American countries which may result in increasing demand for continuous glucose monitoring device. For instance, in September 2019, according to report published in the International Journal of Diabetes and Clinical Research, Mexico (13.6%) had the highest prevalence of diabetes, whereas significant differences between urban and rural areas were observed (7.8% and 1.4%, respectively) in Latin America. Latin America had the maximum prevalence of type-2 Diabetes problems. Furthermore, increasing convenience offered by continuous glucose monitoring devices is expected to drive the growth of the Latin America continuous glucose monitoring device market, as display of glucose trend graph and direction arrows allow diabetic patients to anticipate deflection in glucose highs and lows regularly throughout the day, this may increase demand for continuous glucose monitoring devices, which in turn is expected to drive the market growth. Moreover, technological advancements in continuous glucose monitoring components such as use of sensor with long life expectancy in continuous monitoring devices that eliminates the repetitive replacement of sensors is expected to generate remarkable revenue in the market over the forecast period. Key features of the study • This report provides an in-depth analysis of the Latin America continuous glucose monitoring device market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the Latin America continuous glucose monitoring device market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies • Key companies covered as a part of this study include Medtronic Plc., Abbott, F. Hoffmann-La Roche AG., Johnson & Johnson, Senseonics, Inc, Dexcom, Inc, Insulet Corporation, Tandem Diabetes Care, Inc, Roche Diagnositics, Lifescan, Bayer Health Care, AgaMatrixc Inc., Arkray Inc., and Nova Biomedical Corporation. • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • Latin America continuous glucose monitoring device market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Latin America continuous glucose monitoring device market Market Segmentation • By Component Type o Transmitters o Receivers o Insulin Pumps o Sensors • By End User o Hospitals & Clinics o Homecare o Others (Ambulatory Surgical Centers, and Academic Institutes) • By Region o Mexico o Argentina o Uruguay o Brazil o Colombia o Chile o Peru o Rest of Latin America • Key Players o Medtronic Plc. o Abbott o Hoffmann-La Roche AG. o Johnson & Johnson o Senseonics, Inc o Dexcom, Inc o Insulet Corporation o Tandem Diabetes Care, Inc o Roche Diagnositics o Lifescan o Bayer Health Care o AgaMatrixc Inc. o Arkray Inc. o Nova Biomedical Corporation
目錄 Table of Contents
Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Market Snapshot, By Component Type  Market Snapshot, By End User  Market Snapshot, By Country o Coherent Opportunity Map (COM) 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics  Drivers  Restraints  Market Opportunities o Impact Analysis o Market Trends o PEST Analysis o PORTER’S Five Forces o Mergers and Acquisitions o Product Expiration o Regulatory Scenario 4. Latin America Continuous Glucose Monitoring Device Market, By Component Type, 2026 – 2033, (USD Mn) o Overview  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2026 – 2033  Segment Trends o Transmitters  Overview  Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Mn) o Receivers  Overview  Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Mn) o Insulin Pumps  Overview  Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Mn) o Sensors  Overview  Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Mn) 5. Latin America Continuous Glucose Monitoring Device Market, By End User, 2026 – 2033, (USD Mn) o Overview  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2026 – 2033  Segment Trends o Hospitals & Clinics  Overview  Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Mn) o Homecare  Overview  Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Mn) o Others (Ambulatory Surgical Centers & Academic Institutes)  Overview  Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Mn) 6. Latin America Continuous Glucose Monitoring Device Market, By Country, 2026 – 2033, (USD Mn) o Overview  Market Share Analysis, By Country 2026 and 2033 (%)  Y-o-Y Growth Analysis, By Country, 2026 – 2033  Country Wise Trends o Mexico  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Component Type, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (USD Mn) o Argentina  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Component Type, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (USD Mn) o Uruguay  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Component Type, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (USD Mn) o Brazil  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Component Type, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (USD Mn) o Colombia  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Component Type, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (USD Mn) o Chile  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Component Type, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (USD Mn) o Peru  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Component Type, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (USD Mn) o Rest of Latin America  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Component Type, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (USD Mn) 7. Competitive Landscape o Heat Map Analysis o Company Profiles  Medtronic Plc. o Company Highlights o Product Portfolio o Key Highlights o Financial Performance o Market Strategies  Abbott o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies  F. Hoffmann-La Roche AG. o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies  Johnson & Johnson o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies  Senseonics, Inc o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies  Dexcom, Inc. o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies  Insulet Corporation o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies  Tandem Diabetes Care, Inc o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies  Roche Diagnositics o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies  Lifescan o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies  Bayer Health Care o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies  AgaMatrixc Inc. o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies  Arkray Inc. o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies  Nova Biomedical Corporation o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies 8. Section o References o Research Methodology o About Us and Sales Contact

提及公司

Medtronic Plc.AbbottHoffmann-La Roche AG.Johnson & JohnsonSenseonics, IncDexcom, IncInsulet CorporationTandem Diabetes Care, IncRoche DiagnositicsLifescanBayer Health CareAgaMatrixc Inc.Arkray Inc.Nova Biomedical Corporation

同分類最新報告(醫療器材)

常見問題

這份報告可以先索取樣本嗎?

可以。建議購買前先申請樣本,提出申請後約 2 個工作天內提供,您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算?

報告以美元標價,台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本(單人/多人/企業全站)價格不同,量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付?如何付款?

一般 3–7 個工作天交付,實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票,30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們